R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Separating scientific risk assessment & consumer perception

In pharmaceutical development, conclusions are built on structured laboratory investigations and reproducible data, rather than simple classification.

R&D

Changing Faces: Pharma and biotech hires, May 2026

Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.

R&D

pharmaphorum podcast Episode 266, Parexel - Paul Bridges and Charlotte Moser

Parexel: Flawless execution, policy shifts & patient-centric...

Parexel's Paul Bridges & Charlotte Moser discuss Europe's biotech sector in the face of an innovation cliff.

R&D

Women in STEM: Overcoming exclusionary workplace culture

pharmaphorum speaks with Thermo Fisher Scientific's Tina Liedtky about women in life sciences and leadership.

R&D

Pharma manufacturing, bottles in a factory

BIOSECURE and beyond: What it really means for pharma supply...

The US pharmaceutical industry is entering a new phase of supply chain transformation.

R&D

Solution Spotlight: Inventus Control (Mobile Device Manageme...

Through Inventus Control, Inventus delivers a dedicated Mobile Device Management (MDM) platform for the life sciences sector.